Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Diplomat Pharmacy, Inc. (Diplomat or the Company) (NYSE: DPLO ) securities between February 26, 2018 and February 21, 2019, inclusive (the Class Period).
Law Offices of Howard G. Smith announces that a class action lawsuit has
been filed on behalf of investors who purchased Diplomat Pharmacy, Inc.
(“Diplomat” or the “Company”) (NYSE: DPLO)
securities between February 26, 2018 and February 21, 2019, inclusive
(the “Class Period”). Diplomat investors have until April 25,
2019 to file a lead plaintiff motion.
Investors suffering losses on their Diplomat investments are encouraged
to contact the Law Offices of Howard G. Smith to discuss their legal
rights in this class action at 888-638-4847 or by email to firstname.lastname@example.org.
On February 22, 2019, Diplomat disclosed the postponement of the release
of its Q4 and full-year 2018 earnings as it worked to finalize the
amount of an impairment charge, which was “expected to be equal to a
significant portion of the PBM’s Goodwill and Definite-lived intangible
assets, which total approximately $630 million as of December 31, 2018,
prior to impairment charges.” On this news, shares of fell $7.59 or 56%,
to close at $5.87 on February 22, 2019, thereby injuring investors.
The complaint filed in this class action alleges that, Defendants made
false and/or misleading statements and/or failed to disclose that: (1)
Diplomat had downplayed its success in integrating and growing its PBM
business, which included LDI Integrated and National Pharmaceutical, two
companies Diplomat had acquired in late 2017; (2) consequently, Diplomat
would need to record a non-cash impairment charge upwards of
approximately $630 million relating to its PBM business and these 2017
acquisitions; (3) due to the foregoing, Diplomat would withdraw its
preliminary 2019 full-year outlook issued less than seven weeks prior;
and (4) as a result, defendants’ statements about Diplomat’s business,
operations and prospects were materially false and misleading and/or
lacked a reasonable basis at all relevant times.
If you purchased shares of Diplomat, have information or would like to
learn more about these claims, or have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Howard G. Smith, Esquire, of Law Offices of Howard G.
Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by
telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com,
or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.